Riskpilot← Back to searchSign inGet full accessWaller Medical AB
ABActiveOrg 5590755079Byleslingan 34Medical specialists activities · NACE 8622Est. 20160 employees
Revenue 2025
SEK 474K
-9% vs 2024
EBITDA margin
17.9%
-54% vs 2024
Equity ratio
87.9%
Financial strength
Net profit 2025
SEK 76K
-48% vs 2024
| Revenue | SEK 474K | -9% |
| EBITDA | SEK 85K | -54% |
| Net profit | SEK 76K | -48% |
| Total assets | SEK 840K | +16% |
| Equity | SEK 738K | +12% |
| Employees | 0 | — |
Legal name
Waller Medical AB
Org number
5590755079
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 september 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska erbjuda medicinsk läkarkonsultation samt utbildningar och föreläsningar inom det medicinska området. Bolaget skall även äga och förvalta fast och lös egendom.
Address
Byleslingan 34
Email
cjmwaller@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 445 | 495 | 718 | 523 | 474 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 251 | 219 | 358 | 183 | 85 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 251 | 219 | 358 | 183 | 85 |
| Net financials | — | — | — | 1 | 11 |
| Profit before tax | 252 | 219 | 359 | 184 | 96 |
| Tax | −54 | −45 | −74 | −38 | −20 |
| Net profit | 198 | 174 | 285 | 146 | 76 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 713 | 684 | 775 | 722 | 840 |
| Equity | 622 | 615 | 710 | 661 | 738 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 92 | 69 | 65 | 61 | 102 |
| Total debt | 92 | 69 | 65 | 61 | 102 |
EBITDA margin
17.9%
This company
15.8%
Market median
+13% vs market
20212025
Equity ratio
87.9%
This company
38.2%
Market median
+130% vs market
20212025
Return on equity
10.3%
This company
18.4%
Market median
+44% vs market
20212025
Net profit margin
16.0%
This company
8.1%
Market median
+98% vs market
20212025
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Waller Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Clara Maria Elisabeth Waller | Deputy Board Member | 0 companies |
| Lovisa Maria Elisabeth Waller | Deputy Board Member | 0 companies |
| Pontus Edvin Magnus Waller | Deputy Board Member | 0 companies |
| Carl Johan Magnus Waller | Board of Directors | 0 companies |